NRSNW
NeuroSense Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.05
+0.00%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$0.04
- Revenue estimate
- $535.6K
Latest reported
- Last report date
- Sep 2, 2026
- EPS actual
- -$0.20
- EPS estimate
- -$0.20
- Revenue actual
- —
- Revenue estimate
- $267.8K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -46.3%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026